my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
19-06-2012: Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced that Jason Avery has been appointed as Chief Business Officer.
With a professional background as Head of Business Development at Affitech A/S and Chief Business Officer at Cambridge Antibody Technology, Jason Avery brings extensive industry experience to Merus.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
Merus receives EP patent covering the expression of defined antibody combinations
Merus B.V. announced today that it has been granted the first European patent covering its Oligoclonics® technology from a patent family that already comprises 4 issued US patents. The Oligoclonics® technology entails the manufacturing of at least three antibodies with different specificiti ... more
Merus announces appointment of Jason Avery as Chief Business Officer
Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced that Jason Avery has been appointed as Chief Business Officer.With a professional background as Head of Business Development at Affitech A/S and Chief Business Officer at Cambridge Antibo ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
